Chemical genetics identifies small-molecule modulators of neuritogenesis involving neuregulin-1/ErbB4 signaling

ACS Chemical Neuroscience

Volumn 1, Issue 4, 2010, Pages 325-342

  Kuai, Letian ^a   Wang, Xiang ^b   Madison, Jon M ^a   Schreiber, Stuart L ^a   Scolnick, Edward M ^a   Haggarty, Stephen J ^a,c  

^a BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 4; GEFITINIB; K 252A; NERVE GROWTH FACTOR; NEU DIFFERENTIATION FACTOR;

ANIMAL CELL; ARTICLE; CELL STRAIN; CONTROLLED STUDY; DRUG MECHANISM; DRUG SCREENING; FEASIBILITY STUDY; MOLECULAR GENETICS; MOLECULAR PROBE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PHENOTYPE; RAT; SIGNAL TRANSDUCTION;

EID: 77951697988     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn900046a     Document Type: Article

References (51)

1. Smukste, I. and Stockwell, B. R. (2005) Advances in chemical genetics Annu. Rev. Genomics Hum. Genet. 6, 261-286
2. Harrison, P. J. and Law, A. J. (2006) Neuregulin 1 and schizophrenia: Genetics, gene expression, and neurobiology Biol. Psychiatry 60, 132-140
3. Ross, C. A., Margolis, R. L., Reading, S. A., Pletnikov, M., and Coyle, J. T. (2006) Neurobiology of schizophrenia Neuron 52, 139-153
4. Stefansson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., Brynjolfsson, J., Gunnarsdottir, S., Ivarsson, O., Chou, T. T., Hjaltason, O., Birgisdottir, B., Jonsson, H., Gudnadottir, V. G., Gudmundsdottir, E., Bjornsson, A., Ingvarsson, B., Ingason, A., Sigfusson, S., Hardardottir, H., Harvey, R. P., Lai, D., Zhou, M., Brunner, D., Mutel, V., Gonzalo, A., Lemke, G., Sainz, J., Johannesson, G., Andresson, T., Gudbjartsson, D., Manolescu, A., Frigge, M. L., Gurney, M. E., Kong, A., Gulcher, J. R., Petursson, H., and Stefansson, K. (2002) Neuregulin 1 and susceptibility to schizophrenia Am. J. Hum. Genet. 71, 877-892
5. Benzel, I., Bansal, A., Browning, B. L., Galwey, N. W., Maycox, P. R., McGinnis, R., Smart, D., St Clair, D., Yates, P., and Purvis, I. (2007) Interactions among genes in the ErbB-Neuregulin signalling network are associated with increased susceptibility to schizophrenia Behav. Brain Funct. 3, 31
6. Norton, N., Moskvina, V., Morris, D. W., Bray, N. J., Zammit, S., Williams, N. M., Williams, H. J., Preece, A. C., Dwyer, S., Wilkinson, J. C., Spurlock, G., Kirov, G., Buckland, P., Waddington, J. L., Gill, M., Corvin, A. P., Owen, M. J., and O'Donovan, M. C. (2006) Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia Am. J. Med. Genet., Part B 141, 96-101
7. Silberberg, G., Darvasi, A., Pinkas-Kramarski, R., and Navon, R. (2006) The involvement of ErbB4 with schizophrenia: Association and expression studies Am. J. Med. Genet., Part B 141, 142-148
8. Law, A. J., Kleinman, J. E., Weinberger, D. R., and Weickert, C. S. (2007) Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia Hum. Mol. Genet. 16, 129-141
9. Nicodemus, K. K., Luna, A., Vakkalanka, R., Goldberg, T., Egan, M., Straub, R. E., and Weinberger, D. R. (2006) Further evidence for association between ErbB4 and schizophrenia and influence on cognitive intermediate phenotypes in healthy controls Mol. Psychiatry 11, 1062-1065
10. Law, A. J., Lipska, B. K., Weickert, C. S., Hyde, T. M., Straub, R. E., Hashimoto, R., Harrison, P. J., Kleinman, J. E., and Weinberger, D. R. (2006) Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5 SNPs associated with the disease Proc. Natl. Acad. Sci. U.S.A. 103, 6747-6752
11. Petryshen, T. L., Middleton, F. A., Kirby, A., Aldinger, K. A., Purcell, S., Tahl, A. R., Morley, C. P., McGann, L., Gentile, K. L., Rockwell, G. N., Medeiros, H. M., Carvalho, C., Macedo, A., Dourado, A., Valente, J., Ferreira, C. P., Patterson, N. J., Azevedo, M. H., Daly, M. J., Pato, C. N., Pato, M. T., and Sklar, P. (2005) Support for involvement of neuregulin 1 in schizophrenia pathophysiology, Mol. Psychiatry 10, 366 - 374, 328.
12. Corfas, G., Roy, K., and Buxbaum, J. D. (2004) Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia Nat. Neurosci. 7, 575-580
13. Mei, L. and Xiong, W. C. (2008) Neuregulin 1 in neural development, synaptic plasticity and schizophrenia Nat. Rev. Neurosci. 9, 437-452
14. Chong, V. Z., Thompson, M., Beltaifa, S., Webster, M. J., Law, A. J., and Weickert, C. S. (2008) Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients Schizophrenia Res. 100, 270-280
15. Hahn, C. G., Wang, H. Y., Cho, D. S., Talbot, K., Gur, R. E., Berrettini, W. H., Bakshi, K., Kamins, J., Borgmann-Winter, K. E., Siegel, S. J., Gallop, R. J., and Arnold, S. E. (2006) Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia Nat. Med. 12, 824-828
16. Falls, D. L. (2003) Neuregulins and the neuromuscular system: 10 years of answers and questions J. Neurocytol. 32, 619-647
17. Elenius, K., Choi, C. J., Paul, S., Santiestevan, E., Nishi, E., and Klagsbrun, M. (1999) Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase Oncogene 18, 2607-2615
18. Elenius, K., Corfas, G., Paul, S., Choi, C. J., Rio, C., Plowman, G. D., and Klagsbrun, M. (1997) A novel juxtamembrane domain isoform of HER4/ErbB4. Isoform-specific tissue distribution and differential processing in response to phorbol ester J. Biol. Chem. 272, 26761-26768
19. Carpenter, G. (2003) ErbB-4: Mechanism of action and biology Exp. Cell Res. 284, 66-77
20. Tao, R. H. and Maruyama, I. N. (2008) All EGF(ErbB) receptors have preformed homo- and heterodimeric structures in living cells J. Cell Sci. 121, 3207-3217
21. Linggi, B. and Carpenter, G. (2006) ErbB receptors: New insights on mechanisms and biology Trends Cell Biol. 16, 649-656
22. Bellon, A. (2007) New genes associated with schizophrenia in neurite formation: A review of cell culture experiments Mol. Psychiatry 12, 620-629
23. Greene, L. A. and Tischler, A. S. (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor Proc. Natl. Acad. Sci. U.S.A. 73, 2424-2428
24. Vaskovsky, A., Lupowitz, Z., Erlich, S., and Pinkas-Kramarski, R. (2000) ErbB-4 activation promotes neurite outgrowth in PC12 cells J. Neurochem. 74, 979-987
25. Sardi, S. P., Murtie, J., Koirala, S., Patten, B. A., and Corfas, G. (2006) Presenilin-dependent ErbB4 nuclear signaling regulates the timing of astrogenesis in the developing brain Cell 127, 185-197
26. Vaghefi, H. and Neet, K. E. (2004) Deacetylation of p53 after nerve growth factor treatment in PC12 cells as a post-translational modification mechanism of neurotrophin-induced tumor suppressor activation Oncogene 23, 8078-8087
27. Rankin, S. L., Guy, C. S., and Mearow, K. M. (2005) TrkA NGF receptor plays a role in the modulation of p75NTR expression Neurosci. Lett. 383, 305-310
28. Sergina, N. V., Rausch, M., Wang, D., Blair, J., Hann, B., Shokat, K. M., and Moasser, M. M. (2007) Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3 Nature 445, 437-441
29. Pang, L., Sawada, T., Decker, S. J., and Saltiel, A. R. (1995) Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor J. Biol. Chem. 270, 13585-13588
30. Gambarotta, G., Garzotto, D., Destro, E., Mautino, B., Giampietro, C., Cutrupi, S., Dati, C., Cattaneo, E., Fasolo, A., and Perroteau, I. (2004) ErbB4 expression in neural progenitor cells (ST14A) is necessary to mediate neuregulin-1beta1-induced migration J. Biol. Chem. 279, 48808-48816
31. Kim, Y., Seger, R., Suresh Babu, C. V., Hwang, S. Y., and Yoo, Y. S. (2004) A positive role of the PI3-K/Akt signaling pathway in PC12 cell differentiation Mol. Cells 18, 353-359
32. Ghosh, S., Jennissen, J. D., Liu, X. P., and Uckun, F. M. (2001) 4-[3-Bromo-4-hydroxyphenyl)amino]-6,7-dimethoxyquinazolin-1-ium chloride methanol solvate and 4-[(3-hydroxyphenyl)amino]-6,7-dimethoxy-1-quinazolinium chloride Acta Crystallogr. C57, 76-78
33. Discafani, C. M., Carroll, M. L., Floyd, M. B., Jr., Hollander, I. J., Husain, Z., Johnson, B. D., Kitchen, D., May, M. K., Malo, M. S., Minnick, A. A., Jr., Nilakantan, R., Shen, R., Wang, Y. F., Wissner, A., and Greenberger, L. M. (1999) Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2- butynamide (CL-387,785) Biochem. Pharmacol. 57, 917-925
34. Han, Y., Caday, C. G., Nanda, A., Cavenee, W. K., and Huang, H. J. (1996) Tyrphostin AG 1478 preferentially inhibits human glioma cells expressing truncated rather than wild-type epidermal growth factor receptors Cancer Res. 56, 3859-3861
35. Jani, J. P., Finn, R. S., Campbell, M., Coleman, K. G., Connell, R. D., Currier, N., Emerson, E. O., Floyd, E., Harriman, S., Kath, J. C., Morris, J., Moyer, J. D., Pustilnik, L. R., Rafidi, K., Ralston, S., Rossi, A. M., Steyn, S. J., Wagner, L., Winter, S. M., and Bhattacharya, S. K. (2007) Discovery and pharmacologic characterization of CP-724,714, a selective ErbB2 tyrosine kinase inhibitor Cancer Res. 67, 9887-9893
36. Wakeling, A. E., Guy, S. P., Woodburn, J. R., Ashton, S. E., Curry, B. J., Barker, A. J., and Gibson, K. H. (2002) ZD1839 (Iressa): An orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy Cancer Res. 62, 5749-5754
37. Koizumi, S., Contreras, M. L., Matsuda, Y., Hama, T., Lazarovici, P., and Guroff, G. (1988) K-252a: A specific inhibitor of the action of nerve growth factor on PC 12 cells J. Neurosci. 8, 715-721
38. Doherty, P. and Walsh, F. S. (1989) K-252a specifically inhibits the survival and morphological differentiation of NGF-dependent neurons in primary cultures of human dorsal root ganglia Neurosci. Lett. 96, 1-6
39. Perez-Pinera, P., Hernandez, T., Garcia-Suarez, O., de Carlos, F., Germana, A., Del Valle, M., Astudillo, A., and Vega, J. A. (2006) The Trk tyrosine kinase inhibitor K252a regulates growth of lung adenocarcinomas Mol. Cell. Biochem. 295, 19-26
40. Krivosheya, D., Tapia, L., Levinson, J. N., Huang, K., Kang, Y., Hines, R., Ting, A. K., Craig, A. M., Mei, L., Bamji, S. X., and El-Husseini, A. (2008) ErbB4-neuregulin signaling modulates synapse development and dendritic arborization through distinct mechanisms J. Biol. Chem. 283, 32944-32956
41. Zhang, H., Berezov, A., Wang, Q., Zhang, G., Drebin, J., Murali, R., and Greene, M. I. (2007) ErbB receptors: From oncogenes to targeted cancer therapies J. Clin. Invest. 117, 2051-2058
42. Gerecke, K. M., Wyss, J. M., and Carroll, S. L. (2004) Neuregulin-1beta induces neurite extension and arborization in cultured hippocampal neurons Mol. Cell. Neurosci. 27, 379-393
43. Gu, Z., Jiang, Q., Fu, A. K., Ip, N. Y., and Yan, Z. (2005) Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex J. Neurosci. 25, 4974-4984
44. Kwon, O. B., Longart, M., Vullhorst, D., Hoffman, D. A., and Buonanno, A. (2005) Neuregulin-1 reverses long-term potentiation at CA1 hippocampal synapses J. Neurosci. 25, 9378-9383
45. Li, B., Woo, R. S., Mei, L., and Malinow, R. (2007) The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity Neuron 54, 583-597
46. Bishop, A. C., Ubersax, J. A., Petsch, D. T., Matheos, D. P., Gray, N. S., Blethrow, J., Shimizu, E., Tsien, J. Z., Schultz, P. G., Rose, M. D., Wood, J. L., Morgan, D. O., and Shokat, K. M. (2000) A chemical switch for inhibitor-sensitive alleles of any protein kinase Nature 407, 395-401
47. Tamaki, K., Shotwell, J. B., White, R. D., Drutu, I., Petsch, D. T., Nheu, T. V., He, H., Hirokawa, Y., Maruta, H., and Wood, J. L. (2001) Efficient syntheses of novel C2-alkylated (-)-K252a analogues Org. Lett. 3, 1689-1692
48. Roux, P. P., Dorval, G., Boudreau, M., Angers-Loustau, A., Morris, S. J., Makkerh, J., and Barker, P. A. (2002) K252a and CEP1347 are neuroprotective compounds that inhibit mixed-lineage kinase-3 and induce activation of Akt and ERK J. Biol. Chem. 277, 49473-49480
49. Berg, M. M., Sternberg, D. W., Parada, L. F., and Chao, M. V. (1992) K-252a inhibits nerve growth factor-induced trk proto-oncogene tyrosine phosphorylation and kinase activity J. Biol. Chem. 267, 13-16
50. Gray, B. L., Wang, X., Brown, W. C., Kuai, L., and Schreiber, S. L. (2008) Diversity synthesis of complex pyridines yields a probe of a neurotrophic signaling pathway Org. Lett. 10, 2621-2624
51. Fleisig, H., El-Din El-Husseini, A., and Vincent, S. R. (2004) Regulation of ErbB4 phosphorylation and cleavage by a novel histidine acid phosphatase Neuroscience 127, 91-100